跳至主要内容
临床试验/NCT00310323
NCT00310323已完成不适用

Effect of Chronic Intermittent Nocturnal Hypoxia on Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea

Virginia Commonwealth University2 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2003年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
69
试验地点
2
主要终点
Dextromethorphan urinary molar ratio

研究概览

简要总结

The purpose of this research study is to determine the effect of chronic nighttime low oxygen saturations on selected body systems (liver) that break down drugs in children with obstructive sleep apnea syndrome (OSAS).

详细描述

The purpose of this study is to determine the effect of chronic intermittent nocturnal hypoxia on selected hepatic drug-metabolizing enzyme systems in children with OSAS. The specific aims are to evaluate the activities of cytochrome P450 (CYP)1A2, N-acetyltransferase-2 (NAT-2), xanthine oxidase (XO)and CYP2D6 in children with OSAS and to determine the effect of OSAS treatment on the activities of these enzyme systems.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
4 Years 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children ages 4 to 16 years with suspected uncomplicated OSAS

排除标准

  • Children with complicated OSAS (craniofacial abnormalities, neuromuscular disorders)
  • Children who are receiving medications known to induce or inhibit hepatic CYP1A2, NAT-2, XO, CYP2D6 or CYP3A4 activity
  • Children who are exposed to second hand smoke for greater than 8 hours per day.
  • Children with hypersensitivity to caffeine or dextromethorphan
  • Children who are receiving corticosteroids or thyroid hormone

研究组 & 干预措施

1

Experimental

Children with OSAS identified via sleep study

干预措施: Dextromethorphan (Drug)

1

Experimental

Children with OSAS identified via sleep study

干预措施: Caffeine (Drug)

结局指标

主要结局

Dextromethorphan urinary molar ratio

时间窗: Pre and post T&A

Caffeine urinary molar ratio

时间窗: Pre and post T&A

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Hepatic Drug Biotransformation in Children With... | 临床试验